Nanjing Well Pharmaceutical Group Co.,Ltd.

SHSE:603351 Stock Report

Market Cap: CN¥3.3b

Nanjing Well Pharmaceutical GroupLtd Past Earnings Performance

Past criteria checks 5/6

Nanjing Well Pharmaceutical GroupLtd has been growing earnings at an average annual rate of 0.4%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 10.5% per year. Nanjing Well Pharmaceutical GroupLtd's return on equity is 8.6%, and it has net margins of 11.1%.

Key information

0.4%

Earnings growth rate

-1.2%

EPS growth rate

Chemicals Industry Growth12.1%
Revenue growth rate10.5%
Return on equity8.6%
Net Margin11.1%
Last Earnings Update30 Sep 2024

Recent past performance updates

Nanjing Well Pharmaceutical GroupLtd's (SHSE:603351) Earnings Are Of Questionable Quality

Aug 26
Nanjing Well Pharmaceutical GroupLtd's (SHSE:603351) Earnings Are Of Questionable Quality

Recent updates

Nanjing Well Pharmaceutical GroupLtd's (SHSE:603351) Earnings Are Of Questionable Quality

Aug 26
Nanjing Well Pharmaceutical GroupLtd's (SHSE:603351) Earnings Are Of Questionable Quality

Nanjing Well Pharmaceutical GroupLtd's (SHSE:603351) Upcoming Dividend Will Be Larger Than Last Year's

Jun 07
Nanjing Well Pharmaceutical GroupLtd's (SHSE:603351) Upcoming Dividend Will Be Larger Than Last Year's

Little Excitement Around Nanjing Well Pharmaceutical Group Co.,Ltd.'s (SHSE:603351) Earnings

Jun 06
Little Excitement Around Nanjing Well Pharmaceutical Group Co.,Ltd.'s (SHSE:603351) Earnings

Revenue & Expenses Breakdown

How Nanjing Well Pharmaceutical GroupLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:603351 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,32814711863
30 Jun 241,32113812162
31 Mar 241,23912012358
31 Dec 231,15611212256
30 Sep 231,089959157
30 Jun 231,0468810854
31 Mar 231,0679410856
31 Dec 221,1119512254
30 Sep 221,1299614243
30 Jun 221,14610613445
31 Mar 221,10510312442
31 Dec 211,04210111041
30 Sep 219891097345
30 Jun 21889997939
31 Mar 21808947637
31 Dec 207361007435
30 Sep 207329310334
30 Jun 207751099135
31 Mar 208231228933
31 Dec 198811289232
30 Sep 198621388229
30 Jun 198321277824
31 Mar 198221237825
31 Dec 188011127424
30 Sep 187791095340
30 Jun 187711086235
31 Mar 187201046628
31 Dec 176941076622
31 Dec 1655885870
31 Dec 1549961610
31 Dec 1452845570

Quality Earnings: 603351 has high quality earnings.

Growing Profit Margin: 603351's current net profit margins (11.1%) are higher than last year (8.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 603351's earnings have grown by 0.4% per year over the past 5 years.

Accelerating Growth: 603351's earnings growth over the past year (55%) exceeds its 5-year average (0.4% per year).

Earnings vs Industry: 603351 earnings growth over the past year (55%) exceeded the Chemicals industry -3.6%.


Return on Equity

High ROE: 603351's Return on Equity (8.6%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies